Added to YB: 2025-11-21
Pitch date: 2025-11-19
HIMS [neutral]
Hims & Hers Health, Inc.
-1.44%
current return
Author Info
Asymmetric Investing analyzes stocks that have an asymmetric return potential of 10x (or more) over the next decade. Sign up for the newsletter.
Company Info
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally.
Market Cap
$8.9B
Pitch Price
$36.78
Price Target
N/A
Dividend
N/A
EV/EBITDA
52.94
P/E
73.02
EV/Sales
4.26
Sector
Health Care Providers and Services
Category
growth
Results Are In! Hims & Hers Labs Is Disruption In Action
HIMS (update): New lab testing service ($499 vs $1,220 direct Quest cost) creates stickiness & opens new verticals. Quick signup/results, comprehensive biomarkers, actionable health insights. Opportunity to integrate wearables, nutrition tracking, build holistic relationships beyond prescriptions. Scale advantage over competitors like Superpower/Function in massive TAM.
Read full article (5 min)